Literature DB >> 10980966

Orlistat for the long-term management of obesity.

D L Seidner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10980966     DOI： 10.1007/s11894-999-0115-2

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


× No keyword cloud information.
  9 in total

1.  Orlistat and weight loss.

Authors:  W J McCarthy
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

2.  Lack of interaction between orlistat and oral contraceptives.

Authors:  D Hartmann; C Güzelhan; P B Zuiderwijk; J Odink
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

3.  The effect of orlistat on the pharmacokinetics of phenytoin in healthy volunteers.

Authors:  A T Melia; T E Mulligan; J Zhi
Journal:  J Clin Pharmacol       Date:  1996-07       Impact factor: 3.126

4.  Effect of the lipase inhibitor orlistat on the pharmacokinetics of four different antihypertensive drugs in healthy volunteers.

Authors:  C Weber; Y K Tam; G Schmidtke-Schrezenmeier; J H Jonkmann; P van Brummelen
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

Review 5.  Current estimates of the economic cost of obesity in the United States.

Authors:  A M Wolf; G A Colditz
Journal:  Obes Res       Date:  1998-03

6.  The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.

Authors:  J Zhi; A T Melia; R Guerciolini; S G Koss-Twardy; S M Passe; A Rakhit; J A Sadowski
Journal:  J Clin Pharmacol       Date:  1996-07       Impact factor: 3.126

7.  Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

Authors:  L Sjöström; A Rissanen; T Andersen; M Boldrin; A Golay; H P Koppeschaar; M Krempf
Journal:  Lancet       Date:  1998-07-18       Impact factor: 79.321

Review 8.  Beneficial health effects of modest weight loss.

Authors:  D J Goldstein
Journal:  Int J Obes Relat Metab Disord       Date:  1992-06

9.  Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.

Authors:  M H Davidson; J Hauptman; M DiGirolamo; J P Foreyt; C H Halsted; D Heber; D C Heimburger; C P Lucas; D C Robbins; J Chung; S B Heymsfield
Journal:  JAMA       Date:  1999-01-20       Impact factor: 56.272
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.